Hiromi Fukuda1,2, Hiroshi Doi1, Masaki Okubo1, Misako Kunii1, Taishi Wada1, Hitaru Kishida3, Yosuke Kudo4, Shigeki Yamaguchi5, Satoko Miyatake2,6, Yasuhiro Ito7, Naohisa Ueda3, Shigeru Koyano8, Yuri Uchiyama2,9, Takeshi Mizuguchi2, Naomichi Matsumoto2, Fumiaki Tanaka1 (1.Department of Neurology and Stroke Medicine, Yokohama City University, Japan, 2.Department of Human Genetics, Yokohama City University, Japan, 3.Department of Neurology, Yokohama City University Medical Center, Japan, 4.Department of Neurology, Yokohama Brain and Spine Center, Japan, 5.Department of Neurology, Yokohama Municipal Citizen's Hospital, Japan, 6.Clinical Genetics Department, Yokohama City University Hospital, Japan, 7.Department of Neurology, TOYOTA Memorial Hospital, Japan, 8.Department of Neurology, Yokohama Minami Kyosai Hospital, Japan, 9.Department of Rare Disease Genomics, Yokohama City University Hospital, Japan)
Session information
English Poster Session
English
[Pe-055] English Poster Session 055「Neurogenetics, Gene therapy, and iPS cell 3」
Fri. May 31, 2024 5:15 PM - 6:35 PM Poster (Hall E, E Block, B2F, TIF)
Chair(s): Hiroshi Tsuda (DEPARTMENT OF NEUROLOGY, JUNTENDO UNIVERSITY, Japan), Yoshio Ikeda (Department of Neurology, Gunma University Graduate School of Medicine, Japan)
Takeo Kawano1, Takayuki Kondo1,2, Satoshi Morita1, Mika Suga1,2, Keiko Imamura1, Ayako Nagahashi1, Takako Enami1, Kayoko Tsukita1, Takashi Ayaki3, Naohiro Egawa3, Yumi Yamamoto4, Kazuhiro Ishii5, Masafumi Morimoto6, Toshiki Mizuno7, Yuishin Izumi8, Masafumi Ihara4, Hidekazu Tomimoto9, Hitoshi Osaka10, Ryosuke Takahashi3, Haruhisa Inoue1,2 (1.Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan, 2.iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Japan, 3.Department of Neurology, Kyoto University Graduate School of Medicine, Japan, 4.National Cerebral and Cardiovascular Center, Japan, 5.Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Japan, 6.Department of Pediatrics, Kyoto Prefectural University of Medicine, Japan, 7.Department of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan, 8.Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Japan, 9.Department of Neurology, Graduate School of Medicine, Mie University, Japan, 10.Department of Pediatrics, Jichi Medical University, Japan)
Toshiaki Takahashi1, Rumiko Izumi2,3, Naoki Suzuki2, Chikako Yaginuma4, Naoko Shimakura2, Yasuko Shimosegawa5, Tomoko Totsune1, Yoko Sugimura1, Takahiko Sasaki6, Masaru Yoshioka1, Toru Baba1, Hideki Oizumi1, Hiroyasu Tanaka1, Hitoshi Warita2, Tetsuya Niihori3, Atsushi Takeda1, Yoko Aoki3, Masashi Aoki1 (1.Department of Neurology, NHO Sendai Nishitaga Hospital, Japan, 2.Department of Neurology, Tohoku University School of Medicine, Japan, 3.Department of Medical Genetics, Tohoku University School of Medicine, Japan, 4.Department of Clinical Laboratory, NHO Sendai Nishitaga Hospital, Japan, 5.Department of Neurosurgery, NHO Sendai Nishitaga Hospital, Japan, 6.Department of Internal Medicine, NHO Sendai Nishitaga Hospital, Japan)
Binod K. Yadav1,2, Renu Yadav3, Byoung Soo Shin4,5 (1.Institute of Medicine, Kathmandu, Nepal, 2.Madhesh Institute of Health Science, Janakurdham, Nepal, 3.Department of Dietetics Tribhuvan University Teaching Hospital, Kathmandu, Nepal, Nepal, 4.Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute of Chonbuk National University Hospital, Korea, 5.Department of Neurology, Chonbuk National University Medical School and Hospital, Jeonju, Korea)
Mika Suga1,2, Takayuki Kondo1,2,3, Keiko Imamura1,2,3, Ran Shibukawa1, Yukako Sagara1, Yaya Taketsuna1, Takako Enami2,3, Ayako Nagahashi2,3, Masako Kinoshita4, Toshiyuki Yamamoto5, Yushi Inoue6, Katsuya Kobayashi7, Takefumi Hitomi8, Riki Matsumoto9, Ryosuke Takahashi7, Akio Ikeda7,10, Haruhisa Inoue1,2,3 (1.iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Japan, 2.Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan, 3.Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project, Japan, 4.Department of Neurology, National Hospital Organization Utano National Hospital, Japan, 5.Institute of Medical Genetics, Tokyo Women's Medical University, Japan, 6.National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, Japan, 7.Department of Neurology, Kyoto University Graduate School of Medicine, Japan, 8.Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Japan, 9.Faculty of Medical Sciences, Graduate School of Medicine, Kobe University, Japan, 10.Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine, Japan)